Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Imatinib mesylate in patients with C-Kit expressing adenoid cystic cancer of the salivary glands: a Princess Margaret Hospital phase II consortium study

Imatinib mesylate in patients with C-Kit expressing adenoid cystic cancer of the salivary glands: a Princess Margaret Hospital phase II consortium study. Journal of Clinical Oncology. 2005; 23 :585-590.


Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.